Insider · CIK 0001993170
Jason Parker Brown
Files at KRTX (Karuna Therapeutics, Inc.). First filing -, latest -.
In brief
Jason Parker Brown files SEC Form 4 as CFO at KRTX (Karuna Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jason Parker Brown has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | KRTX Karuna Therapeutics, Inc. | DDisposition to issuer Common Stock | -14,009 | $330.00 | $4.6M | 7,158 | Mar 18, 2024 |
| Mar 18, 2024 | KRTX Karuna Therapeutics, Inc. | DDisposition to issuer Common Stock | -7,158 | $330.00 | $2.4M | 0 | Mar 18, 2024 |
| Mar 18, 2024 | KRTX Karuna Therapeutics, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -10,306 | $330.00 | $3.4M | 0 | Mar 18, 2024 |
| Mar 18, 2024 | KRTX Karuna Therapeutics, Inc. | DDisposition to issuer Option (right to buy)derivative | -3,281 | $230.28 | $756k | 0 | Mar 18, 2024 |
| Mar 18, 2024 | KRTX Karuna Therapeutics, Inc. | DDisposition to issuer Option (right to buy)derivative | -6,562 | $198.36 | $1.3M | 0 | Mar 18, 2024 |
| Mar 18, 2024 | KRTX Karuna Therapeutics, Inc. | DDisposition to issuer Option (right to buy)derivative | -10,312 | $218.03 | $2.2M | 0 | Mar 18, 2024 |
| Mar 18, 2024 | KRTX Karuna Therapeutics, Inc. | DDisposition to issuer Option (right to buy)derivative | -7,100 | $138.21 | $981k | 0 | Mar 18, 2024 |
| Mar 18, 2024 | KRTX Karuna Therapeutics, Inc. | DDisposition to issuer Option (right to buy)derivative | -7,696 | $160.91 | $1.2M | 0 | Mar 18, 2024 |
| Feb 13, 2024 | KRTX Karuna Therapeutics, Inc. | FTax withholding Common Stock | -278 | $318.00 | $88k | 21,167 | Feb 15, 2024 |
| Feb 13, 2024 | KRTX Karuna Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +10,306 | $0.00 | $0 | 10,306 | Feb 15, 2024 |
Questions about Jason Parker Brown
Answered from the filings on this page, as of the latest one.
Is Jason Parker Brown buying or selling?
Jason Parker Brown has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jason Parker Brown's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jason Parker Brown has 0.
Where does Jason Parker Brown file Form 4?
Jason Parker Brown has filed Form 4 at KRTX (Karuna Therapeutics, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.